<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320264</url>
  </required_header>
  <id_info>
    <org_study_id>UMCIRB 19-000914</org_study_id>
    <nct_id>NCT04320264</nct_id>
  </id_info>
  <brief_title>Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis</brief_title>
  <official_title>Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>East Carolina University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>East Carolina University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The focus of this proposal is on overweight (25&gt;BMI&lt;30 kg/m2

      ) subjects, as these individuals exhibit a high risk of becoming obese and/or developing
      metabolic diseases. We hypothesize that in some overweight individuals there is a &quot;metabolic
      program&quot; in skeletal muscle which predisposes them to the development of obesity. Findings
      may lead to clinical screening tools for determining risk for obesity in non-obese
      individuals and targeting this group for prevention.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine if an increased reliance on anaerobic glycolysis in muscle shifts fasting metabolism from fat towards carbohydrate utilization, which results in metabolic inflexibility and subsequent metabolic disease (i.e. obesity).</measure>
    <time_frame>5 years</time_frame>
    <description>Carbohydrate/fat oxidation (RER) in the fasting condition</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Metabolic Inflexibility</condition>
  <arm_group>
    <arm_group_label>Low oxidizers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High oxidizers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxidative capacity</intervention_name>
    <description>VO2 peak</description>
    <arm_group_label>High oxidizers</arm_group_label>
    <arm_group_label>Low oxidizers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-50 years old

          -  BMI of 25 - 30 kg/m2

          -  BMI &gt; 40kg/m2

          -  Lactate levels in top and lower 25%

        Exclusion Criteria:

          -  Pregnant women

          -  Mentally disabled

          -  Prisoners

          -  Smokers

          -  Subjects with heart disease

          -  Type 1 and 2 diabetes

          -  Endocrine disease

          -  Hypertension

          -  Musculoskeletal disease

          -  Peripheral occlusion

          -  Hepatic disease

          -  Have had weight fluctuations exceeding + 3% in the previous 12 months

          -  On medications which alter carbohydrate metabolism will not be studied
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Josh Yang</last_name>
    <phone>252-744-0114</phone>
    <email>yangj15@ecu.edu</email>
  </overall_contact>
  <reference>
    <citation>Ryan TE, Brophy P, Lin CT, Hickner RC, Neufer PD. Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements. J Physiol. 2014 Aug 1;592(15):3231-41. doi: 10.1113/jphysiol.2014.274456. Epub 2014 Jun 20.</citation>
    <PMID>24951618</PMID>
  </reference>
  <reference>
    <citation>Fisher-Wellman KH, Davidson MT, Narowski TM, Lin CT, Koves TR, Muoio DM. Mitochondrial Diagnostics: A Multiplexed Assay Platform for Comprehensive Assessment of Mitochondrial Energy Fluxes. Cell Rep. 2018 Sep 25;24(13):3593-3606.e10. doi: 10.1016/j.celrep.2018.08.091.</citation>
    <PMID>30257218</PMID>
  </reference>
  <reference>
    <citation>Chondronikola M, Magkos F, Yoshino J, Okunade AL, Patterson BW, Muehlbauer MJ, Newgard CB, Klein S. Effect of Progressive Weight Loss on Lactate Metabolism: A Randomized Controlled Trial. Obesity (Silver Spring). 2018 Apr;26(4):683-688. doi: 10.1002/oby.22129. Epub 2018 Feb 24.</citation>
    <PMID>29476613</PMID>
  </reference>
  <reference>
    <citation>Goodpaster BH, Sparks LM. Metabolic Flexibility in Health and Disease. Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015. Review.</citation>
    <PMID>28467922</PMID>
  </reference>
  <reference>
    <citation>Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1009-17. doi: 10.1152/ajpendo.90558.2008. Epub 2008 Sep 2. Review.</citation>
    <PMID>18765680</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Metabolic Inflexibility</keyword>
  <keyword>Obesity</keyword>
  <keyword>Anaerobic glycolysis</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

